You are here: Home


The Institute of Biochemistry and Molecular Biology is, together with the Institute of Molecular Medicine and Cell Research, located in the new building of the Centre for Biochemistry and Molecular Cell Research (ZBMZ). The institute belongs to the Theoretikum of the Faculty of Medicine at the Albert-Ludwigs-University of Freiburg. It is mainly devoted to basic research, but the work includes medical and biotechnological implications which have led to collaborations with clinical institutes and the industry. The major common themes of our research are the cellular mechanisms of targeting, transport, folding and modification of proteins. The studies are performed with single-cell organisms (yeast and prokaryotes) and cell cultures. This research is currently funded by grants from the DFG (German Research Council), the SFB746 (Collaborative Research Centre on "Functional specificity by coupling and modification of proteins") SFB 992 (Collaborative Research Centre on "Medical Epigenetics: from basic mechanisms to clinical applications"), the Cluster of Excellence "Centre of Biological Signalling Studies (bioss)", the Spemann Graduate School of Biology and Medicine, the EU, and the Landesforschungsprogramm.


The Institute of Biochemistry and Molecular Biology consists of independent research groups with a common infrastructure (technical management, administration, mechanics, instrument shop, photographic laboratory). It provides the complete teaching program in Biochemistry for medical students. It sustains numerous scientific and social interactions between the laboratories. One such activity is a seminar series organized by the PhD students and postdocs of the Institute at which members of the Institute and guest speakers communicate their data. All seminars of the Institute are given in English since we have students and postdocs from several countries, including Australia, China, France, Korea, Morocco, Poland, Romania, Serbia, Sweden and USA.



Doorway and doorman all in one

The protein complex TOM regulates protein access to cell power plants – Chris Meisinger aims to find out which signal pathways can change that selection
» more

Funding Approval for Two Collaborative Research Centers (CRCs) in the Life Sciences and Medicine

The University of Freiburg will receive roughly 25.8 million euros from the Deutsche Forschungsgemeinschaft for the funded projects

» more


Dissolving protein traffic jam at the entrance of mitochondria

Researchers from Freiburg discovered a novel mechanism that ensures obstacle-free protein traffic into the powerhouse of the cell
» more